As part of a phase 1 clinical trial of a variant-specific COVID-19 vaccine developed by Moderna, pharmacist Sue Lasicka gives a shot of the vaccine candidate to volunteer Suzanne Uvelli-Spencer, MD, on April 1, 2021, at Kaiser Permanente Washington Health Research Institute in Seattle.
Credit:
Courtesy of Jonathan Rabinovitz
Seattle-based clinical trial tweaks mRNA vaccines to fight Covid variants
Apr 08, 2021
Researchers are testing a new Covid-19 vaccine. Part of the clinical trial is taking place here in Seattle. The trial will tweak the Moderna vaccine to fight one variant of the Covid virus, B1351. That's the variant first discovered in South Africa.
This interview has been edited for clarity.